ArchivesMagazine - 22 May 2025Investors alert to new twists and turns in the weight-loss drug revolution Attention is shifting from market leaders to who might thrive when generic copycat products arrive 22 May 2025|Dan Coatsworth|by Dan Coatsworth Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email < Buy into chemicals company Victrex at an attractive valuation Should investors be looking to emerging markets after Liberation Day? > Issue: 22 May 2025 - Page 33 | Contents Next: Should investors be looking to emerging markets after Liberation Day? Previous: Buy into chemicals company Victrex at an attractive valuation Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email Dan Coatsworth Issue Contents Ask Rachel What is the 4% rule and how does it work? Dan Coatsworth Investors alert to new twists and turns in the weight-loss drug revolution Editor's View The argument for gold prices to move yet higher Feature Is Apple ex-growth? What it means if the days of rapid expansion are over Should investors be looking to emerging markets after Liberation Day? Unpicking what the new Mansion House Accord means for pension savers Great Ideas Time to cash out at H&T after takeover approach Buy into chemicals company Victrex at an attractive valuation Why you can count on JPMorgan Claverhouse as it dials up the income News What tender offer means for Polar Capital Global Financials Trust investors Moody’s cuts US credit rating These are the stocks ‘guru’ investors have been buying and selling this year It’s business as usual for contractor Costain as shares hit five-year high Victorian Plumbing shares hit new low as group plans MFI comeback Personal Finance I’ve maxed out my ISA: now what? Week Ahead B&M’s new boss needs to restore confidence in discounter’s growth story Nvidia: Markets brace for the biggest earnings show in town
